Interventional Stroke Therapies in the Elderly: Are We Helping?

References

1. 1.↵
   Tissue plasminogen activator for acute ischemic stroke: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333: 1581–87

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Wolpert SM,
   2. Bruckmann H,
   3. Greenlee R,
   4. et al

   . Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator: the rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol 1993;14: 3–13

   Abstract/FREE Full Text
3. 3.↵
   1. Weimar C,
   2. Ziegler A,
   3. Konig IR,
   4. et al

   . Predicting functional outcome and survival after acute ischemic stroke. J Neurol 2002;249: 888–95

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Tanne D,
   2. Gorman MJ,
   3. Bates VE,
   4. et al

   . Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: the tPA stroke survey experience. Stroke 2000;31: 370–75

   Abstract/FREE Full Text
5. 5.↵
   1. Zeevi N,
   2. Chhabra J,
   3. Silverman IE,
   4. et al

   . Acute stroke management in the elderly. Cerebrovasc Dis 2007;23: 304–08

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Mishra NK,
   2. Ahmed N,
   3. Andersen G,
   4. et al

   . Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. BMJ 2010;341: c6046
7. 7.↵
   1. Ringleb PA,
   2. Schwark C,
   3. Kohrmann M,
   4. et al

   . Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome. J Neurol Neurosurg Psychiatry 2007;78: 690–93

   Abstract/FREE Full Text
8. 8.↵
   1. Hallevi H,
   2. Barreto AD,
   3. Liebeskind DS,
   4. et al

   . Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke. Stroke 2009;40: 1780–85

   Abstract/FREE Full Text
9. 9.↵
   1. Smith WS

   . Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke: results of the Multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 2006;27: 1177–82

   Abstract/FREE Full Text
10. 10.↵
    1. Smith WS,
    2. Sung G,
    3. Saver J,
    4. et al

    . Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39: 1205–12

    Abstract/FREE Full Text
11. 11.↵
    1. del Zoppo GJ,
    2. Higashida RT,
    3. Furlan AJ,
    4. et al

    . PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke—PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29: 4–11
12. 12.↵
    1. Appelboom G,
    2. Strozyk D,
    3. Meyers PM,
    4. et al

    . Current recommendations for endovascular interventions in the treatment of ischemic stroke. Curr Atheroscler Rep 2010;12: 244–50

    CrossRefPubMed
13. 13.↵
    1. Greenberg SM,
    2. Vonsattel JP

    . Diagnosis of cerebral amyloid angiopathy: sensitivity and specificity of cortical biopsy. Stroke 1997;28: 1418–22

    Abstract/FREE Full Text
14. 14.↵
    1. de Boer A,
    2. Kluft C,
    3. Kroon JM,
    4. et al

    . Liver blood flow as a major determinant of the clearance of recombinant human tissue-type plasminogen activator. Thromb Haemost 1992;67: 83–87

    PubMedWeb of Science
15. 15.↵
    1. Zeevi N,
    2. Pachter J,
    3. McCullough LD,
    4. et al

    . The blood-brain barrier: geriatric relevance of a critical brain-body interface. J Am Geriatr Soc 2010;58: 1749–57

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Bauer KA,
    2. Weiss LM,
    3. Sparrow D,
    4. et al

    . Aging-associated changes in indices of thrombin generation and protein C activation in humans: Normative Aging Study. J Clin Invest 1987;80: 1527–34

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Meier N,
    2. Nedeltchev K,
    3. Brekenfeld C,
    4. et al

    . Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke. Stroke 2009;40: 1729–37

    Abstract/FREE Full Text
18. 18.↵
    1. Kidwell CS,
    2. Saver JL,
    3. Carneado J,
    4. et al

    . Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke 2002;33: 717–24

    Abstract/FREE Full Text
19. 19.↵
    1. Brekenfeld C,
    2. Remonda L,
    3. Nedeltchev K,
    4. et al

    . Symptomatic intracranial haemorrhage after intra-arterial thrombolysis in acute ischaemic stroke: assessment of 294 patients treated with urokinase. J Neurol Neurosurg Psychiatry 2007;78: 280–85

    Abstract/FREE Full Text
20. 20.↵
    1. Brott T,
    2. Adams HP Jr.,
    3. Olinger CP,
    4. et al

    . Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20: 864–70

    Abstract/FREE Full Text
21. 21.↵
    1. Lyden P,
    2. Lu M,
    3. Jackson C,
    4. et al

    . Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis—NINDS tPA Stroke Trial Investigators. Stroke 1999;30: 2347–54

    Abstract/FREE Full Text
22. 22.↵
    1. Higashida RT,
    2. Furlan AJ,
    3. Roberts H,
    4. et al

    . Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34: e109–37

    Abstract/FREE Full Text
23. 23.↵
    1. Shah S,
    2. Vanclay F,
    3. Cooper B

    . Improving the sensitivity of the Barthel index for stroke rehabilitation. J Clin Epidemiol 1989;42: 703–09

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Wolfe CD,
    2. Crichton SL,
    3. Heuschmann PU,
    4. et al

    . Estimates of outcomes up to ten years after stroke: analysis from the prospective South London stroke register. PLoS Med 2011;8: e1001033. Epub 2011 May 17

    CrossRefPubMed
25. 25.↵
    1. Turtzo LC,
    2. McCullough LD

    . Sex differences in stroke. Cerebrovasc Dis 2008;26: 462–74

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Paciaroni M,
    2. Agnelli G,
    3. Corea F,
    4. et al

    . Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome—results of a prospective multicenter study. Stroke 2008;39: 2249–56

    Abstract/FREE Full Text
27. 27.↵
    1. Prabhakaran S,
    2. Rivolta J,
    3. Vieira JR,
    4. et al

    . Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol 2010;67: 559–63. Epub 2010 Mar 8

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Bang OY,
    2. Saver JL,
    3. Liebeskind DS,
    4. et al

    . Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology 2007;68: 737–42

    Abstract/FREE Full Text
29. 29.↵
    1. Derex L,
    2. Hermier M,
    3. Adeleine P,
    4. et al

    . Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J Neurol Neurosurg Psychiatry 2005;76: 70–75

    Abstract/FREE Full Text
30. 30.↵
    1. Dougherty G,
    2. Varro J

    . A quantitative index for the measurement of the tortuosity of blood vessels. Med Eng Phys 2000;22: 567–74

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Kim D,
    2. Ford GA,
    3. Kidwell CS,
    4. et al

    . Intra-arterial thrombolysis for acute stroke in patients 80 and older: a comparison of results in patients younger than 80 years. AJNR Am J Neuroradiol 2007;28: 159–63

    Abstract/FREE Full Text
32. 32.↵
    1. Nighoghossian N,
    2. Hermier M,
    3. Adeleine P,
    4. et al

    . Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study. Stroke 2002;33: 735–42

    Abstract/FREE Full Text
33. 33.↵
    1. Furlan A,
    2. Higashida R,
    3. Wechsler L,
    4. et al

    . Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study−a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282: 2003–11

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Brinjikji W,
    2. Rabinstein AA,
    3. Kallmes DF,
    4. et al

    . Patient outcomes with endovascular embolectomy therapy for acute ischemic stroke: a study of the national inpatient sample 2006 to 2008. Stroke 2011; 42: 1648–52. Epub 2011 Apr 14

    Abstract/FREE Full Text
35. 35.↵
    1. ElDesoky ES

    . Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther 2007;14: 488–98

    CrossRefPubMed
36. 36.↵
    1. Marik PE

    . Management of the critically ill geriatric patient. Crit Care Med 2006;34 (9 suppl): S176–82

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Qureshi AI,
    2. Suri MF,
    3. Georgiadis AL,
    4. et al

    . Intra-arterial recanalization techniques for patients 80 years or older with acute ischemic stroke: pooled analysis from 4 prospective studies. AJNR Am J Neuroradiol 2009;30: 1184–89

    Abstract/FREE Full Text
38. 38.↵
    1. Petcu EB,
    2. Sfredel V,
    3. Platt D,
    4. et al

    . Cellular and molecular events underlying the dysregulated response of the aged brain to stroke: a mini-review. Gerontology 2008;54: 6–17. Epub 2007 Dec 21

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Pundik S,
    2. McWilliams-Dunnigan L,
    3. Blackham KL,
    4. et al

    . Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke. J Stroke Cerebrovasc Dis 2008;17: 266–72

    CrossRefPubMed
40. 40.↵
    1. Hussein HM,
    2. Georgiadis AL,
    3. Vazquez G,
    4. et al

    . Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke: a multicenter study. AJNR Am J Neuroradiol 2010;31: 454–58. Epub 2010 Jan 14

    Abstract/FREE Full Text
41. 41.↵
    1. Amenta PS,
    2. Ali MS,
    3. Dumont AS,
    4. et al

    . Computed tomography perfusion-based selection of patients for endovascular recanalization. Neurosurg Focus 2011;30: E6

    PubMed
42. 42.↵
    1. Williams DO,
    2. Borer J,
    3. Braunwald E,
    4. et al

    . Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. Circulation 1986;73: 338–46

    Abstract/FREE Full Text